Apyx Medical Corp
APYXNasdaqCIK 719135HealthcareFiscal year ends Dec 31
Reports and events: 290 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2015-03-1207:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-15-001640 |
| 2015-03-1116:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-15-001634 |
| 2015-03-0213:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-15-001442 |
| 2015-02-2714:13 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001477932-15-001424 |
| 2014-11-1012:43 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001477932-14-005906 |
| 2014-11-0710:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001009448-14-000055 |
| 2014-10-0315:16 ET | 8-K | 8.01 Other events | 0001009448-14-000049 |
| 2014-10-0314:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001009448-14-000047 |
| 2014-08-0817:26 ET | 10-Q | Quarterly reportPeriod 2014-06-30 | 0001477932-14-004161 |
| 2014-08-0716:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001009448-14-000041 |
| 2014-07-2116:27 ET | 8-K | 5.07 Shareholder vote results | 0001009448-14-000039 |
| 2014-07-1717:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001009448-14-000037 |
| 2014-07-0216:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001009448-14-000035 |
| 2014-06-0916:25 ET | DEF 14A | Proxy statementPeriod 2013-07-16 | 0001009448-14-000033 |
| 2014-05-1911:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001009448-14-000031 |
| 2014-05-1516:46 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001477932-14-002645 |
| 2014-05-0816:56 ET | 10-K/A | Annual report, amendedPeriod 2013-12-31 | 0001477932-14-002386 |
| 2014-05-0816:44 ET | 8-K | 4.02 Non-reliance on financial statements | 0001009448-14-000029 |
| 2014-05-0813:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001009448-14-000028 |
| 2014-04-0215:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001009448-14-000019 |
| 2014-03-3117:01 ET | 10-K | Annual reportPeriod 2013-12-31 | 0001477932-14-001436 |
| 2014-03-2413:39 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001477932-14-001202 |
| 2013-12-1615:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-13-006069 |
| 2013-11-2715:39 ET | 8-K | 8.01 Other events | 0001009448-13-000057 |
| 2013-11-1409:37 ET | 10-Q | Quarterly reportPeriod 2013-09-30 | 0001477932-13-005424 |
| 2013-10-2816:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001009448-13-000047 |
| 2013-09-2509:21 ET | 10-Q/A | Quarterly report, amendedPeriod 2013-06-30 | 0001477932-13-004338 |
| 2013-09-2509:11 ET | 8-K | 4.02 Non-reliance on financial statements | 0001009448-13-000045 |
| 2013-08-1407:06 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001477932-13-003628 |
| 2013-08-1311:25 ET | 8-K | 8.01 Other events | 0001009448-13-000043 |
| 2013-07-1716:58 ET | 8-K | 5.07 Shareholder vote results | 0001009448-13-000039 |
| 2013-05-3108:33 ET | DEF 14A | Proxy statementPeriod 2013-07-16 | 0001009448-13-000035 |
| 2013-05-1506:29 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001140361-13-020761 |
| 2013-04-2315:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001009448-13-000025 |
| 2013-04-0107:10 ET | 10-K | Annual reportPeriod 2012-12-31 | 0001140361-13-014654 |
| 2013-03-2016:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001009448-13-000019 |
| 2012-11-1406:27 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001140361-12-046982 |
| 2012-10-2611:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001009448-12-000079 |
| 2012-08-1614:18 ET | 10-K/A | Annual report, amendedPeriod 2011-12-31 | 0001140361-12-037401 |
| 2012-08-1614:12 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-12-037399 |
| 2012-08-1408:12 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001140361-12-036720 |
| 2012-07-1315:51 ET | 8-K | 5.07 Shareholder vote results | 0001009448-12-000071 |
| 2012-05-2210:53 ET | DEF 14A | Proxy statementPeriod 2012-07-12 | 0001009448-12-000049 |
| 2012-05-1507:04 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001140361-12-025110 |
| 2012-03-2906:41 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001140361-12-017979 |
| 2012-03-2815:17 ET | 8-K | 5.08 Item not in the standard list | 0001009448-12-000036 |
| 2012-02-2810:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001009448-12-000024 |
| 2011-12-1511:03 ET | 8-K | 1.02 Termination of a material agreement | 0001009448-11-000107 |
| 2011-11-2908:37 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001009448-11-000103 |
| 2011-11-1407:12 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0001140361-11-053005 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:09 ET. Listed shows no prices and gives no investment advice.